Papillary renal neoplasm with reverse polarity: a clinicopathological analysis.
10.3760/cma.j.cn112151-20210627-00461
- Author:
Rong Hao JI
1
;
Xiao Tong WANG
1
;
Rui LI
1
;
Sheng Bing YE
1
;
Xuan WANG
1
;
Heng Hui MA
1
;
Zhen Feng LU
1
;
Qiu RAO
1
;
Qiu Yuan XIA
1
Author Information
1. Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.
- Publication Type:Journal Article
- MeSH:
Biomarkers, Tumor;
Carcinoma, Renal Cell/genetics*;
Female;
Humans;
In Situ Hybridization, Fluorescence;
Kidney;
Kidney Neoplasms/genetics*;
Male;
Middle Aged;
Prognosis
- From:
Chinese Journal of Pathology
2022;51(1):23-27
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To study the clinical pathological characteristics, immunophenotype, molecular changes and prognosis of the papillary renal neoplasm with reverse polarity (PRNRP). Methods: Nine cases of PRNRP, diagnosed from 2013 to 2019, were retrieved from the Department of Pathology of Nanjing Jinling Hospital, Nanjing University School of Medicine. Histomorphology, immunophenotype and molecular genetics were analyzed with review of the literatures. Results: There were five male and four female patients, aged from 49 to 70 years, with an average age of 60.1 years. During a mean follow-up of 29 months, one patient died for other cause, and the others survived without disease. Microscopically, the tumor cells arranged in papillary structure with a fibrovascular core, the surface of which was covered with a single layer of cuboidal or columnar cells. The most prominent feature was that the tumor nuclei located at the top of the cytoplasm far from the basement membrane, and they were monotonous in size and arranged neatly with no or few nucleoli. Immunohistochemically, all nine cases of PRNRP showed diffuse positive expression of CK7 and E-cadherin, various degrees of P504s expression, and no expression of CD10 and CD117, with a Ki-67 index of 1%-3%. Unlike other papillary renal cell carcinoma, the nine cases of PRNRP all showed characteristic positive expression of GATA3. The fluorescence in situ hybridization assay showed that the majority of PRNRPs (8/9) did not have triploids on chromosomes 7 and 17. The sequencing of the KRAS gene confirmed the presence of a nonsense KRAS mutation in 8 of the 9 cases. Conclusions: PRNRP is a subtype of papillary renal cell carcinoma with characteristic morphological, immunophenotypic and molecular features, and indolent behaviors. More data are needed to define PRNRP as "carcinoma", and a definitive diagnosis of PRNRP is of great significance for proper treatment choice and accurate prognostication.
